ANIP logo

ANIP

ANI Pharmaceuticals Inc.

$79.49
-$1.03(-1.28%)
64
Overall
75
Value
63
Tech
55
Quality
How is this score calculated?
Market Cap
$1.94B
Volume
351.46K
52W Range
$62.14 - $99.50
Target Price
$109.88

Company Overview

Mkt Cap$1.94BPrice$79.49
Volume351.46KChange-1.28%
P/E Ratio24.8Open$81.00
Revenue$883.4MPrev Close$80.52
Net Income$78.3M52W Range$62.14 - $99.50
Div YieldN/ATarget$109.88
Overall64Value75
Quality55Technical63

No chart data available

About ANI Pharmaceuticals Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Sector: Healthcare
Industry: Biotechnology

Latest News

ANI Pharmaceuticals Shareholders Approve Amended 2022 Incentive Plan

ANI Pharmaceuticals ( ($ANIP) ) just unveiled an update. ANI Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders on May 21, 2026, wh...

TipRanks Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2ANIP$79.49-1.3%351.46K
3
4
5
6

Get ANI Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.